2Morrow develops, licenses, and distributes behavioral digital health and DTx products. With over a dozen published studies and one of the few Phase III RCTs in digital health, 2Morrow takes an evidence-based approach to staying healthy. 2Morrow has employee wellness programs in a market that supports population wellness and well-being initiatives. 2Morrow has multiple products in the pipeline that expand on their work in substance use and for people living with chronic conditions.

2Strands is an innovative early-stage precision diagnostic company developing blood-based monitoring tests for cancer patients. Our vision is to revolutionize oncology practice with a solution that delivers a unique combination of accuracy, affordability, and speed. 2Strands' innovative assay chemistry uses proprietary biochemical steps and next-gen computational modeling to achieve exceptional performance.

4baseCare provides precision oncology solutions with advanced genomics to help cancer patients. The company focuses on leveraging advanced genomic technologies to provide personalized cancer treatment solutions. By analyzing the genetic profile of cancer patients, 4baseCare aims to identify targeted therapies that are more effective and have fewer side effects compared to traditional treatments. Their services include genomic testing, data interpretation, and personalized treatment recommendations, which are designed to improve patient outcomes and support healthcare providers in delivering precision medicine. The company collaborates with various stakeholders, including hospitals, research institutions, and pharmaceutical companies, to advance cancer care and research.

Access Vascular is a healthcare center that offers non-invasive testing for arterial and venous diseases.

Aevice Health Pte Ltd is a Singapore-based medtech spin-off from Nanyang Technological University at the forefront of addressing chronic respiratory disease, one of the generation’s biggest healthcare challenges. The company’s non-invasive wearable devices enable the early detection of cardiopulmonary abnormalities remotely and in real-time, so that patients can receive fast and targeted care from the ease of their homes. Clinicians can also gain insights into their patients’ health and track their responses to treatment plans easily from the Aevice analytical platform. In Aevice Health, our mission is to drive medical innovations that transform healthcare, improve outcomes and empower lives. More information about the company can be found at www.aevice.com.

Aksense develops a portable diagnostic biosensor for the diagnosis of healthcare-associated infections.

Alva Health develops healthcare wearables for remote stroke monitoring. The company's wearables are patented and operate round-the-clock to identify stroke signatures and connect consumers with emergency services. Alva Health aims to transform stroke treatment and the ability to create, validate, and market revolutionary neurotechnologies.

Anumana develops AI algorithms that analyze ECG data to support early diagnosis of cardiovascular conditions. The company focuses on enhancing cardiac care through innovative technology, providing tools that assist healthcare professionals in identifying potential heart issues. Anumana's platform extends beyond diagnostics, aiming to improve patient outcomes throughout the entire continuum of cardiovascular care, including perioperative and acute settings. By utilizing machine learning techniques, Anumana aims to refine screening processes, making it easier for clinicians to detect heart diseases and intervene promptly. This approach contributes to more efficient healthcare delivery and better management of cardiovascular health.

Aopia Biosciences is a biotechnology business focused on developing cutting-edge bioengineering solutions and technologies for biomedical research, diagnostics, and therapeutic applications.

Astek Diagnostics develops a platform that guides physicians in prescribing appropriate antibiotics for patients with bacterial sepsis in one hour. It employs a single-use cartridge to identify bacterial infection in the urine in substantially less time by detecting the oxygen consumption of bacterial species.

Atom Bioworks is a developer of a pattern-recognition enabled DNA-antibody-mimic rational design platform for sensing and therapeutics of infectious diseases.